PHK
ITCI

Point72 Hong Kong’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Point72 Hong Kong’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,840
Closed -$237K – 670
2024
Q4 		$237K Sell
2,840
-3,453
-55% -$284K 0.01% 279
2024
Q3 		$460K Sell
6,293
-38,075
-86% -$2.86M 0.03% 249
2024
Q2 		$3.04M Buy
+44,368
New +$3.08M 0.18% 115
2021
Q2 		– Sell
-1,316
Closed -$45K – 2426
2021
Q1 		$45K Buy
+1,316
New +$45.7K ﹤0.01% 1306
2020
Q4 		– Sell
-2,284
Closed -$59K – 2099
2020
Q3 		$59K Buy
+2,284
New +$52.1K 0.01% 655
2019
Q4 		– Sell
-3,455
Closed -$26K – 1505
2019
Q3 		$26K Buy
3,455
+3,137
+986% +$30.1K 0.01% 677
2019
Q2 		$4K Buy
+318
New +$4.08K ﹤0.01% 955
2019
Q1 		– Sell
-19
Closed – – 1329
2018
Q4 		$0 Buy
+19
New +$307 ﹤0.01% 1259
2018
Q3 		– Sell
-1,335
Closed -$24K – 1231
2018
Q2 		$24K Buy
+1,335
New +$27.1K 0.01% 554
2017
Q4 		– Sell
-978
Closed -$15K – 1135
2017
Q3 		$15K Buy
+978
New +$14.4K 0.01% 438
2017
Q1 		– Sell
-22
Closed – – 1043
2016
Q4 		$0 Buy
+22
New +$311 ﹤0.01% 1073

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Point72 Hong Kong's ITCI Position: Q1 2025 in Review

Point72 Hong Kong sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 2,840 shares — an estimated $237K sold.

Point72 Hong Kong first reported a position in ITCI in Q4 2016 and held it in 11 quarters. The position peaked at $3.04M in Q2 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Point72 Hong Kong reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 2,840 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $237K.
  • Point72 Hong Kong first reported a position in Intra-Cellular Therapies Inc. in Q4 2016 and held it in 11 quarters.
  • Point72 Hong Kong's Intra-Cellular Therapies Inc. position peaked at $3.04M in Q2 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Point72 Hong Kong's 13F filing for Q1 2025, filed 15 May 2025.